BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 25148840)

  • 21. Anti-angiogenic activity of carebastine: a plausible mechanism affecting airway remodelling.
    De Luisi A; Mangialardi G; Ria R; Acuto G; Ribatti D; Vacca A
    Eur Respir J; 2009 Oct; 34(4):958-66. PubMed ID: 19357149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 12-Deoxyphorbol 13-palmitate inhibit VEGF-induced angiogenesis via suppression of VEGFR-2-signaling pathway.
    Xu HY; Pan YM; Chen ZW; Lin Y; Wang LH; Chen YH; Jie TT; Lu YY; Liu JC
    J Ethnopharmacol; 2013 Apr; 146(3):724-33. PubMed ID: 23434607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiangiogenic Potential of Microbial Metabolite Elaiophylin for Targeting Tumor Angiogenesis.
    Lim HN; Jang JP; Han JM; Jang JH; Ahn JS; Jung HJ
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29498688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluocinolone inhibits VEGF expression via glucocorticoid receptor in human retinal pigment epithelial (ARPE-19) cells and TNF-alpha-induced angiogenesis in chick chorioallantoic membrane (CAM).
    Ayalasomayajula SP; Ashton P; Kompella UB
    J Ocul Pharmacol Ther; 2009 Apr; 25(2):97-103. PubMed ID: 19284324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective effects and mechanisms of total alkaloids of Rubus alceaefolius Poir on non‑alcoholic fatty liver disease in rats.
    Zheng H; Zhao J; Zheng Y; Wu J; Liu Y; Peng J; Hong Z
    Mol Med Rep; 2014 Oct; 10(4):1758-64. PubMed ID: 25051256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-inflammatory effects of total alkaloids from Rubus alceifolius Poir [corrected]. on non-alcoholic fatty liver disease through regulation of the NF-κB pathway.
    Zhao J; Zheng H; Liu Y; Lin J; Zhong X; Xu W; Hong Z; Peng J
    Int J Mol Med; 2013 Apr; 31(4):931-7. PubMed ID: 23426790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-dose metronomic chemotherapy with cisplatin: can it suppress angiogenesis in H22 hepatocarcinoma cells?
    Shen FZ; Wang J; Liang J; Mu K; Hou JY; Wang YT
    Int J Exp Pathol; 2010 Feb; 91(1):10-6. PubMed ID: 20096070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sulforaphane exerts anti-angiogenesis effects against hepatocellular carcinoma through inhibition of STAT3/HIF-1α/VEGF signalling.
    Liu P; Atkinson SJ; Akbareian SE; Zhou Z; Munsterberg A; Robinson SD; Bao Y
    Sci Rep; 2017 Oct; 7(1):12651. PubMed ID: 28978924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of tumor-induced angiogenesis by taspine isolated from Radix et Rhizoma Leonticis and its mechanism of action in vitro.
    Zhang Y; He L; Meng L; Luo W; Xu X
    Cancer Lett; 2008 Apr; 262(1):103-13. PubMed ID: 18180095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of alpha-tocopherol ether-linked acetic acid in VEGF-induced angiogenesis and the possible mechanisms in human umbilical vein endothelial cells.
    Chuang CH; Liu CH; Lu TJ; Hu ML
    Toxicol Appl Pharmacol; 2014 Dec; 281(3):310-6. PubMed ID: 25447407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kallistatin, a novel anti-angiogenesis agent, inhibits angiogenesis via inhibition of the NF-κB signaling pathway.
    Huang KF; Huang XP; Xiao GQ; Yang HY; Lin JS; Diao Y
    Biomed Pharmacother; 2014 May; 68(4):455-61. PubMed ID: 24721321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. γ-Tocotrienol inhibits angiogenesis of human umbilical vein endothelial cell induced by cancer cell.
    Li Y; Sun WG; Liu HK; Qi GY; Wang Q; Sun XR; Chen BQ; Liu JR
    J Nutr Biochem; 2011 Dec; 22(12):1127-36. PubMed ID: 21292465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-angiogenic quassinoid-rich fraction from Eurycoma longifolia modulates endothelial cell function.
    Al-Salahi OS; Kit-Lam C; Majid AM; Al-Suede FS; Mohammed Saghir SA; Abdullah WZ; Ahamed MB; Yusoff NM
    Microvasc Res; 2013 Nov; 90():30-9. PubMed ID: 23899415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evodiamine exerts anti-tumor effects against hepatocellular carcinoma through inhibiting β-catenin-mediated angiogenesis.
    Shi L; Yang F; Luo F; Liu Y; Zhang F; Zou M; Liu Q
    Tumour Biol; 2016 Sep; 37(9):12791-12803. PubMed ID: 27449032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anti-angiogenetic effect of arenobufagin in vitro and in vivo].
    Liu JS; Zhang DM; Chen MF; Li MM; Luo QD; Kurihara H; Ye WC
    Yao Xue Xue Bao; 2011 May; 46(5):527-33. PubMed ID: 21800539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo.
    Zhong ZF; Hoi PM; Wu GS; Xu ZT; Tan W; Chen XP; Cui L; Wu T; Wang YT
    J Ethnopharmacol; 2012 Jun; 141(2):721-7. PubMed ID: 21911050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deguelin inhibits human hepatocellular carcinoma by antiangiogenesis and apoptosis.
    Lee JH; Lee DH; Lee HS; Choi JS; Kim KW; Hong SS
    Oncol Rep; 2008 Jul; 20(1):129-34. PubMed ID: 18575727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Berberine inhibits angiogenic potential of Hep G2 cell line through VEGF down-regulation in vitro.
    Jie S; Li H; Tian Y; Guo D; Zhu J; Gao S; Jiang L
    J Gastroenterol Hepatol; 2011 Jan; 26(1):179-85. PubMed ID: 21175812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibiting angiogenesis with human single-chain variable fragment antibody targeting VEGF.
    Hosseini H; Rajabibazl M; Ebrahimizadeh W; Dehbidi GR
    Microvasc Res; 2015 Jan; 97():13-8. PubMed ID: 25250517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deoxypodophyllotoxin exerts both anti-angiogenic and vascular disrupting effects.
    Jiang Z; Wu M; Miao J; Duan H; Zhang S; Chen M; Sun L; Wang Y; Zhang X; Zhu X; Zhang L
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1710-9. PubMed ID: 23702033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.